Výsledky vyhledávání - "Nukhet, Tuzuner"

Discrepancies in Lymphoma Diagnosis Over the Years: A 13-Year Experience in a Tertiary Center

Autor: Nukhet Tuzuner, Ahu Senem Demiröz, Nuray Bassullu, Neval Özkaya

Publikováno v: Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 34, Iss 1, Pp 81-88 (2017)

In the past, accurate diagnosis of lymphoma was challenging since there were multiple competing classification systems that caused confusion and debate. After establishment of the World Health Organization lymphoma classification, lymphomas still rem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3794505562ad2dc45d530cd6a55e5bb1
http://europepmc.org/articles/PMC5451693

Zobrazit plný text záznamu

Case report of a young patient with transthyretin amyloidosis associated with Gly67Ala mutation

Autor: Umut Yilmaz, Nergis Serin, Suleyman Yildirim, Muhlis Cem Ar, Selma Bozcan, Veysel Sabri Hancer, Aykut Ferhat Celik, Ayse Salihoglu, Nukhet Tuzuner

16th International Symposium on Amyloidosis (ISA) -- MAR 26-29, 2018 -- Kumamoto, JAPAN Hereditary transthyretin-mediated amyloidosis (hATTR) is a rare, systemic and progressive autosomal dominant disease caused by mutations in the TTR gene. Systemic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd0e7bd200a394f41b13bb88ccfcbed2
https://hdl.handle.net/20.500.12713/645

Zobrazit plný text záznamu

Pleural tuberculosis in a patient with untreated type 1 Gaucher disease

Autor: Ezel Erşen, Buge Oz, Ahmet Emre Eskazan, Akif Turna, Nukhet Tuzuner, Ahu Senem Demiröz, Ozgecan Dulgar

Publikováno v: Journal of Infection and Chemotherapy. 22:53-57

Gaucher disease (GD) is an autosomal recessive glycolipid storage disorder, due to deficiency of the lysosomal enzyme glucocerebrosidase, leading to accumulation of the substrate glucocerebroside in the cells of the macrophage-monocyte system. Patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa41198f20bbbc6c7587beaa7de8f9da
https://doi.org/10.1016/j.jiac.2015.08.009

Zobrazit plný text záznamu

Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha

Autor: Ahmet Emre Eskazan, Teoman Soysal, Ayse Salihoglu, Nukhet Tuzuner, Tugrul Elverdi, Zafer Baslar, Isil Bavunoglu, Elif Guzel, Aydın Tunçkale, Şeniz Öngören, Deniz Eyice, Muhlis Cem Ar

Publikováno v: Indian Journal of Hematology and Blood Transfusion. 32:272-277

Congenital dyserythropoietic anemias are a rare group of inherited anemias characterized by ineffective erythropoiesis and distinct morphological abnormalities in the erythroblasts. Interferon alpha has been shown to be effective in type 1 congenital

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3e067d73efef5c509c972e2a5b16887
https://doi.org/10.1007/s12288-015-0600-8

Zobrazit plný text záznamu

Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature

Autor: Ahmet Emre Eskazan, Ugur Ozbek, Zafer Baslar, Teoman Soysal, Nukhet Tuzuner, Tugrul Elverdi, Sibel Aylin Uğur Işeri, Selin Berk, Fevzi Firat Yalniz, Şeniz Öngören, Veysel Suzan, Isil Erdogan Ozunal, Yucel Erbilgin, Sercan Savci, Yildiz Aydin, Muhlis Cem Ar, Ayse Salihoglu

Publikováno v: Hematology (Amsterdam, Netherlands). 23(4)

Newer tyrosine kinase inhibitors (TKIs) (bosutinib, ponatinib) and allogeneic hematopoietic stem cell transplantation (allo-HSCT) can be utilized as a salvage therapy in patients with chronic myeloid leukemia (CML) who failed two lines (imatinib →

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd7167efb135ebad78234fefd448f9f
https://pubmed.ncbi.nlm.nih.gov/28990873

Zobrazit plný text záznamu

Classification of the Acute Leukemias: Cytochemical and Morphologic Considerations

Autor: Nukhet Tuzuner, John M. Bennett

Publikováno v: Neoplastic Diseases of the Blood ISBN: 9783319642628
Neoplastic Diseases of the Blood ISBN: 9781461437635

The acute leukemias are a heterogeneous group of neoplasms affecting uncommitted or partially committed hematopoietic stem cells. The origin of the malignant neoplasm is almost invariably within the marrow. Replacement of the marrow pulp or the repre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70902cd204c529024fb2c452c9d333c8
https://doi.org/10.1007/978-3-319-64263-5_14

Zobrazit plný text záznamu

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

Publikováno v: Clinical lymphoma, myelomaleukemia. 17(12)

Background The molecular response at 3 months of the original imatinib (OI) in patients with chronic myeloid leukemia has prognostic significance; however, this has never been tested for generic imatinib (GI). Patients and Methods We evaluated the BC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5840f2b63f9a78ab22632f10a564e281
https://pubmed.ncbi.nlm.nih.gov/28847475

Zobrazit plný text záznamu

Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion

Autor: Zafer Baslar, Burhan Ferhanoglu, Teoman Soysal, Fevzi Firat Yalniz, Yildiz Aydin, Enes Ali Kurt, Deniz Eyice, Ayse Salihoglu, Muhlis Cem Ar, Seniz Ongoren Aydin, Ahmet Emre Eskazan, Ugur Ozbek, Nukhet Tuzuner, Tugrul Elverdi

Publikováno v: Leukemia Research. 38:781-787

Dasatinib is a potent second generation TKI, and it is widely used in patients with CML, both in the up-front setting and failure after imatinib. Lymphocytosis in cases receiving dasatinib therapy has been shown to be associated with pleural effusion

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47ab8fef3fbf7c111408de58a185f013
https://doi.org/10.1016/j.leukres.2014.04.004

Zobrazit plný text záznamu

Dendritic cell sarcoma: A pooled analysis including 462 cases with presentation of our case series

Autor: Nukhet Tuzuner, Caner Saygin, Didem Uzunaslan, Mustafa Şenocak, Mustafa Ozguroglu

Publikováno v: Critical Reviews in Oncology/Hematology. 88:253-271

Dendritic cell tumors are extremely rare and current knowledge on these tumors is limited. The characteristics of three dendritic cell sarcoma subtypes and their optimal treatment approaches are not fully clarified. We aimed to make a systematic revi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c694137e8bd2d8da40298a40c9f6c7cc
https://doi.org/10.1016/j.critrevonc.2013.05.006

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání